The drug, lecanemab, was approved by the FDA this summer. The UW study focuses on patients without symptoms who have early ...

Medicare will cover new class of Alzheimer's drugs if fully approved by FDA, with limits Jun 2, 2023 The real costs of the new Alzheimer's drug, most of which will fall to taxpayers Aug 14, 2023 ...

The EU recommends Anavex proceed with a full approval application for Alzheimer's drug Blarcamesine based on full Phase 2b/3 trial data. The U.S. FDA may grant accelerated approval to Anavex's ...

A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer's dementia.

Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover the drug, I have met with Alzheimer’s patients and their loved ones who are anxious to ...

American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...

A small pharmaceutical company in Research Triangle Park is considering its next steps after seeing positive results in a clinical study evaluating its treatment for Alzheimer's disease.

Just four months after the Food and Drug Administration gave full approval to a new Alzheimer’s drug, it’s estimated that ...

There's a new weight loss drug that has been given FDA approval. Dr. Mike Cirigliano talks about it. Trump posts ‘Thanksgiving message’ at 2 a.m. with a list of insults NASA Warns Solar Storm ...

TAMPA, Fla. — November is Alzheimer's Awareness Month. It's estimated that 1 in 8 Floridians are currently living with the disease and are supported by more than 800,000 unpaid family caregivers.

When my friend Ira was diagnosed with Pancreatic cancer he went through surgery and chemotherapy, but was still facing a short life expectancy. Then he was lucky to be 1 of only 26 patients in an ...

A new poll from the University of Michigan confirms that older adults will take results seriously: Ninety-seven percent of ...